EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NEK1 autophosphorylation is disrupted by amyotrophic lateral sclerosis-associated missense variants: activity biomarkers and structural insights

Shalini Agarwal, Syed Arif Abdul Rehman, Ivan M Muñoz, Axel Knebel, Paul J Hop, Robert Gourlay, Fiona Brown, Thomas Macartney, Iolo Squires, Jan H Veldink, Kevin P Kenna, John Rouse und 1 weitere

Open Biology · 07.10.2026 · 16 (10)

DOI: 10.1098/rsob.260209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Biology, online erschienen am 28.10.2026. Verfasst von Shalini Agarwal und 12 weiteren Autor:innen. Beteiligte Einrichtung: MRC Protein Phosphorylation & Ubiquitylation Unit, Faculty of Life Sciences , University of Dundee, Dundee, UK. Hauptthemen laut MEDLINE: NIMA-Related Kinase 1, Amyotrophic Lateral Sclerosis, Mutation, Missense. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Greater Houston Community Foundation, UK Medical Research Council, National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rare variants in NEK1, encoding a serine/threonine kinase, are among the most consistently implicated genetic contributors to amyotrophic lateral sclerosis (ALS), reported in approximately 2–3% of cases. Yet, while recent studies have characterized the cell biological consequences of NEK1 loss-of-function, the biochemical effects of ALS-associated missense variants on kinase activity have not been directly investigated. This distinction is mechanistically important, because missense alleles encode mutant proteins rather than simply reducing protein dosage. Here, we provide the most comprehensive cell-based phosphoproteomic map of NEK1 phosphorylation to date, identifying 10 recurrent phosphorylation sites across independent expression and acquisition conditions. We experimentally assign pSer14, pThr156 and pSer418 as NEK1 autophosphorylation sites using kinase-dead controls, targeted extracted ion chromatogram analysis, phosphosite mutagenesis and phosphospecific antibodies. Leveraging activation-loop pThr156 as a read-out of NEK1 activity, we assessed nine ALS-associated missense variants spanning the major functional regions of the protein. Among catalytic-domain variants, R261C produced the most robust reduction in pThr156 autophosphorylation, R232C produced a smaller reduction, and R232H increased pThr156; the basic-region variant, A313T, also showed a smaller reduction. Structural modelling provides a mechanistic framework for understanding these variant-specific effects. Our study establishes the first activity-based framework for functional classification of NEK1 missense variants, and provides direct evidence that ALS-associated missense variants can alter NEK1 autophosphorylation through a mechanism distinct from simple haploinsufficiency. The phosphospecific antibodies, isogenic cell lines and curated phosphoproteomic datasets generated here provide a community resource for future studies of NEK1 regulation, variant interpretation and therapeutic target validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NIMA-Related Kinase 1Amyotrophic Lateral SclerosisMutation, MissensePhosphorylationHumansBiomarkersModels, Molecular

Stichwörter der Autor:innen

NEK1 kinaseamyotrophic lateral sclerosisautophosphorylationmotor neuron disease

Substanzen

NIMA-Related Kinase 1NEK1 protein, humanBiomarkers

Autor:innen und Institutionen

  • MRC Protein Phosphorylation & Ubiquitylation Unit, Faculty of Life Sciences , University of Dundee, Dundee, UK.
  • Division of Molecular, Cell and Developmental Biology, Faculty of Life Sciences , University of Dundee, Dundee, UK.
  • Division of Genome Integrity, Faculty of Life Sciences , University of Dundee, Dundee, UK.
  • Protein Production and Assay Development, MRC Protein Phosphorylation & Ubiquitylation Unit, Faculty of Life Sciences, University of Dundee , Dundee, UK.
  • Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University , Utrecht, The Netherlands.
  • Mass Spectrometry Facility, MRC Protein Phosphorylation & Ubiquitylation Unit, Faculty of Life Sciences, University of Dundee , Dundee, UK.

ORCID-Profile: Arpan R Mehta

Förderung

  • Greater Houston Community Foundation
  • UK Medical Research Council
  • National Institute for Health and Care Research
  • Dementias Platform UK
  • Royal Society

Zitieren

APA

Agarwal, S., Rehman, S. A. A., Muñoz, I. M., Knebel, A., Hop, P. J., Gourlay, R., Brown, F., Macartney, T., Squires, I., Veldink, J. H., Kenna, K. P., Rouse, J., & Mehta, A. R. (2026). NEK1 autophosphorylation is disrupted by amyotrophic lateral sclerosis-associated missense variants: activity biomarkers and structural insights. Open Biology, 16(10). https://doi.org/10.1098/rsob.260209

Vancouver

Agarwal S, Rehman SAA, Muñoz IM, Knebel A, Hop PJ, Gourlay R, et al. NEK1 autophosphorylation is disrupted by amyotrophic lateral sclerosis-associated missense variants: activity biomarkers and structural insights. Open Biology. 2026;16(10). doi:10.1098/rsob.260209

BibTeX
@article{Agarwal2026,
  author = {Agarwal, Shalini and Rehman, Syed Arif Abdul and Muñoz, Ivan M and Knebel, Axel and Hop, Paul J and Gourlay, Robert and Brown, Fiona and Macartney, Thomas and Squires, Iolo and Veldink, Jan H and Kenna, Kevin P and Rouse, John and Mehta, Arpan R},
  title = {NEK1 autophosphorylation is disrupted by amyotrophic lateral sclerosis-associated missense variants: activity biomarkers and structural insights},
  journal = {Open Biology},
  year = {2026},
  volume = {16},
  number = {10},
  doi = {10.1098/rsob.260209}
}
Kostenlos starten →